Variation in Antibiotic Prescription in High-Risk Febrile Neutropenia in Portuguese Hospitals

被引:0
|
作者
Freitas, Marta [1 ]
Andrade, Paulo [2 ,3 ]
Pinto, Ricardo [4 ]
Trigo, Fernanda [4 ]
Azevedo, Ana [1 ,5 ,6 ]
Almeida, Francisco [1 ,2 ,6 ]
机构
[1] Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, P-4200039 Porto, Portugal
[2] Unidade Local Saude Sao Joao, Ctr Epidemiol Hosp, Unidade Prevencao & Controlo Infecao & Resistencia, P-4200319 Porto, Portugal
[3] Unidade Local Saude Sao Joao, Serv Doencas Infecciosas, P-4200319 Porto, Portugal
[4] Unidade Local Saude Sao Joao, Serv Hematol Clin, P-4200319 Porto, Portugal
[5] Unidade Local Saude Sao Joao, Ctr Epidemiol Hosp, P-4200319 Porto, Portugal
[6] Univ Porto, Inst Saude Publ, Lab Invest Integrat & Translac Saude Populac ITR, EPIUnit, P-4050600 Porto, Portugal
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 09期
关键词
febrile neutropenia; high risk; antimicrobial stewardship; survey; guidelines; INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; OUTPATIENT MANAGEMENT; FEVER; RESISTANCE; ONCOLOGY; THERAPY;
D O I
10.3390/antibiotics13090822
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Febrile neutropenia (FN) is a potentially severe entity, particularly in hemato-oncologic patients who have higher incidence of colonization with multidrug-resistant bacteria. Discrepancies among guidelines contribute to divergence in antimicrobial practices. Our objective was to assess the variation of practices in antimicrobial therapy in high-risk FN among Portuguese hematologists. Methods: We conducted a cross-sectional study through the implementation of an online survey, open to all clinical hematologists in the country. To characterize practice patterns regarding critical elements in FN management, three clinical vignettes were designed to describe typical situations where narrow-spectrum empiric antibiotics (vignette 1), short-course therapy (vignette 2) and de-escalation (vignette 3) could be performed. The remaining questions characterized clinical experience, department size, and differentiation and decision-making process regarding FN antibiotic therapy. Results: The survey yielded 31 responses from 11 hospitals across four regions. All respondents opted for empiric narrow-spectrum antibiotics, 22.6% opted for short-course therapy (mostly senior specialists from larger settings) and 35.5% for de-escalation (mostly young specialists). Availability of an FN protocol seemed to favor both approaches. These findings should be complemented by qualitative assessments of barriers to best practices and should support the need for interventions to improve antibiotic use in febrile neutropenia.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Evaluation of glycopeptide prescription in high-risk febrile neutropenia: A monocentric study of North Africa
    Boufrikha, Wiem
    Rakez, Rim
    Laabidi, Baraa
    Laatiri, Mohamed Adnene
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (06) : 964 - 970
  • [2] Antibiotic treatment in children with High Risk Febrile Neutropenia
    Munoz B, Eliana
    Cristobal Ossa A, Juan
    Villarroel C, Milena
    Santolaya D P, Maria Elena
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2008, 79 (04): : 381 - 387
  • [3] Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia
    Alegria, William
    Marini, Bernard L.
    Gregg, Kevin Sellery
    Bixby, Dale Lee
    Perissinotti, Anthony
    Nagel, Jerod
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (03): : 245 - 252
  • [4] Antimicrobial stewardship in high-risk febrile neutropenia patients
    Adrien Contejean
    Salam Abbara
    Ryme Chentouh
    Sophie Alviset
    Eric Grignano
    Nabil Gastli
    Anne Casetta
    Lise Willems
    Etienne Canouï
    Caroline Charlier
    Frédéric Pène
    Julien Charpentier
    Jeanne Reboul-Marty
    Rui Batista
    Didier Bouscary
    Solen Kernéis
    Antimicrobial Resistance & Infection Control, 11
  • [5] Patterns of vancomycin use in high-risk febrile neutropenia
    Meranda, Matthew
    Sheqwara, Jawad
    Shallal, Anita
    Alangaden, George
    Dillon, William
    Veve, Michael
    Mann, Yasmeen
    Tamr, Amer
    Raslan, Shahm
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Antimicrobial stewardship in high-risk febrile neutropenia patients
    Contejean, Adrien
    Abbara, Salam
    Chentouh, Ryme
    Alviset, Sophie
    Grignano, Eric
    Gastli, Nabil
    Casetta, Anne
    Willems, Lise
    Canoui, Etienne
    Charlier, Caroline
    Pene, Frederic
    Charpentier, Julien
    Reboul-Marty, Jeanne
    Batista, Rui
    Bouscary, Didier
    Kerneis, Solen
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2022, 11 (01)
  • [7] Advances in antibacterial treatment of adults with high-risk febrile neutropenia
    Contejean, Adrien
    Maillard, Alexis
    Canoui, Etienne
    Kerneis, Solen
    Fantin, Bruno
    Bouscary, Didier
    Parize, Perrine
    Garcia-Vidal, Carolina
    Charlier, Caroline
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (09) : 2109 - 2120
  • [8] Clinical profile of high-risk febrile neutropenia in a tertiary care hospital
    Bhojaraja, Mohan V.
    Kanakalakshmi, Sushma T.
    Prabhu, Mukhyaprana M.
    Thomas, Joseph
    AUSTRALASIAN MEDICAL JOURNAL, 2016, 9 (06): : 142 - 151
  • [9] Clinical experience with three combination regimens for the treatment of high-risk febrile neutropenia
    Serefhanoglu, K
    Ersoy, Y
    Serefhanoglu, S
    Aydogdu, I
    Kuku, I
    Kaya, E
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2006, 35 (01) : 11 - 16
  • [10] High-risk febrile neutropenia and its management in children with solid tumors and lymphoma
    Kose, Dogan
    Emiroglu, Melike
    Koksal, Yavuz
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, 45 (03) : 655 - 662